NCT06730256
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +20 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,963 public trials
2,020 recruiting studies
Immunoproliferative Disorders trial results
Recruiting
Limited-duration Teclistamab
NCT05932680
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
- Columbia University New York, United States
- Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT07198256
- Conditions
- Brain Diseases, Brain Metastases, Adult, Brain Neoplasms, +21 more
- Locations
-
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
Recruiting
Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma
NCT05296070
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- University of Miami Miami, Florida, United States
- Emory University Atlanta, Georgia, United States
- Vanderbilt University Nashville, Tennessee, United States
NCT07199296
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Ruijin Hospital Shanghai, China
Recruiting
A Study of GNC-038 Injection in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT05623982
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
- Harbin First Hospital Haerbin, Heilongjing, China
- Qingdao Central Hospital Qingdao, Shandong, China
NCT05779605
- Conditions
- Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +9 more
- Locations
-
- University Hospital Brno Brno, Czechia
Recruiting
MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)
NCT06534437
- Conditions
- Aberrant Motor Behavior in Dementia, Aggression, Behavior, +16 more
- Locations
-
- Centre Hospitalier Le Mans Le Mans, France
- CHU de Lille - Hôpital Claude Huriez Lille, France
- CHU de Limoges - CHU Dupuytren Limoges, France
- Hospices Civils De Lyon - Hôpital Lyon Sud Lyon, France
Recruiting
Linperlisib Combination With Cyclophosphamide, Prednisone, and Thalidomide (CPT) in R/R NHL
NCT07195799
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China
- Conditions
- Acute Lymphoblastic Leukemia (ALL), Adult, Acute Myeloid Leukemia (AML), Anemia, +45 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States